Item type | Home library | Class number | URL | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Electronic book | Stenhouse Library (Kingston Hospital) Online | Link to resource | Available |
Includes bibliographical references and index.
Print version record.
How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Despr�es -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.
There are no comments on this title.